Intra-Subject Hormone Variation

受试者体内激素变化

基本信息

  • 批准号:
    6888907
  • 负责人:
  • 金额:
    $ 92.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-05-01 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by applicant) The dearth of reliable data to permit estimation of intra-subject variability in male hormones over time (both short and longer-term) is a glaring deficiency in the field of male reproductive endocrinology. Data from our Massachusetts Male Aging Study (MMAS) suggests that hypogonadism may not be a stable syndrome over time. Moreover, data on intra-subject variability is essential to the design of any scientifically credible trial of androgen replacement in men. These data are also important at the level of patient care- especially the adequacy of a single early morning serum sample for diagnostic purposes. This study has three primary aims: (1) To obtain reliable estimates of short term (day-to-day) and longer-term (six months) intra-subject variation in hormone levels in adult men. While the main focus is on testosterone (total, free, bioavailable and the free androgen index), other major hormones (DHT, SHBG, LH, prolactin, DHEA, DHEAS, cortisol, androstenedione, androstanediol glucoronide (3-alpha-diol G) and estrone) are included because of rapidly growing interest in their actions, and because it's cost-efficient also to gather these data in a single study; (2) To determine if the intra-subject variation in hormone levels changes with age (a few studies have focused on relatively young men); (3)To examine the magnitude of any seasonal variability (this could affect clinical interpretation of results and power calculations in clinical trials). It is also important to estimate the relative contribution of assay variation and biological variation to total intra-subject variation. The proposed research builds on nearly 20 years of work on the MMAS and results will have an impact at several levels- the epidemiology of male endocrine change, clinical trials design and the clinical management of individual patients with androgen deficiency.
描述:(由申请人提供)缺乏可靠的数据来估计男性激素随时间(短期和长期)的受试者内部变异性,这是男性生殖内分泌学领域的一个明显缺陷。我们马萨诸塞州男性衰老研究(MMAS)的数据表明性腺功能减退可能不是一个稳定的综合征。此外,受试者内部变异的数据对于设计任何科学可信的男性雄激素替代试验至关重要。这些数据在患者护理水平上也很重要,特别是用于诊断目的的单一清晨血清样本的充分性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donald Brambilla其他文献

Donald Brambilla的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donald Brambilla', 18)}}的其他基金

Emerging Infectious Diseases Research Centers Coordination Center (EIDRC CC)
新发传染病研究中心协调中心 (EIDRC CC)
  • 批准号:
    10166768
  • 财政年份:
    2020
  • 资助金额:
    $ 92.71万
  • 项目类别:
Clinical Trials Development Resource for Hematologic Disorders (U24)
血液疾病临床试验开发资源 (U24)
  • 批准号:
    8693647
  • 财政年份:
    2012
  • 资助金额:
    $ 92.71万
  • 项目类别:
Clinical Trials Development Resource for Hematologic Disorders (U24)
血液疾病临床试验开发资源 (U24)
  • 批准号:
    8353779
  • 财政年份:
    2012
  • 资助金额:
    $ 92.71万
  • 项目类别:
Clinical Trials Development Resource for Hematologic Disorders (U24)
血液疾病临床试验开发资源 (U24)
  • 批准号:
    8882535
  • 财政年份:
    2012
  • 资助金额:
    $ 92.71万
  • 项目类别:
Clinical Trials Development Resource for Hematologic Disorders (U24)
血液疾病临床试验开发资源 (U24)
  • 批准号:
    8539071
  • 财政年份:
    2012
  • 资助金额:
    $ 92.71万
  • 项目类别:
SMARTT COORDINATING CENTER
SMARTT协调中心
  • 批准号:
    8355876
  • 财政年份:
    2010
  • 资助金额:
    $ 92.71万
  • 项目类别:
Data Coordinating Center for the Sickle Cell Disease Clinical Research Network
镰状细胞病临床研究网络数据协调中心
  • 批准号:
    7219455
  • 财政年份:
    2006
  • 资助金额:
    $ 92.71万
  • 项目类别:
Data Coordinating Center for the Sickle Cell Disease
镰状细胞病数据协调中心
  • 批准号:
    7060122
  • 财政年份:
    2006
  • 资助金额:
    $ 92.71万
  • 项目类别:
Intra-Subject Hormone Variation
受试者体内激素变化
  • 批准号:
    7062128
  • 财政年份:
    2004
  • 资助金额:
    $ 92.71万
  • 项目类别:
Intra-Subject Hormone Variation
受试者体内激素变化
  • 批准号:
    6708642
  • 财政年份:
    2004
  • 资助金额:
    $ 92.71万
  • 项目类别:

相似海外基金

CELLULAR UPTAKE AND ACTIONS OF ANDROGEN BINDING PROTEIN
雄激素结合蛋白的细胞摄取和作用
  • 批准号:
    3021486
  • 财政年份:
    1989
  • 资助金额:
    $ 92.71万
  • 项目类别:
CLONING ANDROGEN BINDING PROTEIN CDNAS IN LAMBDA
在 Lambda 中克隆雄激素结合蛋白 CDNAS
  • 批准号:
    3437650
  • 财政年份:
    1987
  • 资助金额:
    $ 92.71万
  • 项目类别:
ANDROGEN BINDING PROTEIN AND OTHER TESTICULAR PROTEINS
雄激素结合蛋白和其他睾丸蛋白
  • 批准号:
    4694284
  • 财政年份:
  • 资助金额:
    $ 92.71万
  • 项目类别:
FUNCTIONAL CAPACITY OF INDIVIDUAL SERTOLI CELLS; ANDROGEN-BINDING PROTEIN
单个支持细胞的功能能力;
  • 批准号:
    3909398
  • 财政年份:
  • 资助金额:
    $ 92.71万
  • 项目类别:
STRUCTURE AND FUNCTION OF ANDROGEN-BINDING PROTEIN
雄激素结合蛋白的结构和功能
  • 批准号:
    5212527
  • 财政年份:
  • 资助金额:
    $ 92.71万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了